Quarterly report · Q2

Period2022-06-01 → 2022-11-30
Filed2023-01-13
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 51
MetricValuePeriodScopeSource row
Revenue¥3.1bn2022-06-01 → 2022-11-30StandaloneNet sales
Revenue¥5.7bn2021-06-01 → 2022-05-31StandaloneNet sales (5-year summary)
Revenue¥2.8bn2021-06-01 → 2021-11-30StandaloneNet sales
Operating income¥225m2022-06-01 → 2022-11-30StandaloneOperating income
Operating income¥323m2021-06-01 → 2021-11-30StandaloneOperating income
Ordinary income¥208m2022-06-01 → 2022-11-30StandaloneOrdinary income
Ordinary income¥423m2021-06-01 → 2022-05-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥324m2021-06-01 → 2021-11-30StandaloneOrdinary income
Profit before tax¥208m2022-06-01 → 2022-11-30StandaloneIncome before income taxes
Profit before tax¥324m2021-06-01 → 2021-11-30StandaloneIncome before income taxes
Net income¥149m2022-06-01 → 2022-11-30StandaloneProfit loss
Net income¥456m2021-06-01 → 2022-05-31StandaloneNet income loss (5-year summary)
Net income¥262m2021-06-01 → 2021-11-30StandaloneProfit loss
Total assets¥5.0bnat 2022-11-30StandaloneAssets
Total assets¥4.8bnat 2022-05-31StandaloneAssets
Total assets¥4.5bnat 2021-11-30StandaloneTotal assets (5-year summary)
Total liabilities¥3.2bnat 2022-11-30StandaloneLiabilities
Total liabilities¥3.1bnat 2022-05-31StandaloneLiabilities
Net assets / equity¥1.8bnat 2022-11-30StandaloneNet assets
Net assets / equity¥1.7bnat 2022-05-31StandaloneNet assets
Net assets / equity¥1.6bnat 2021-11-30StandaloneNet assets (5-year summary)
Cash and deposits¥765mat 2022-11-30StandaloneCash and deposits
Cash and deposits¥865mat 2022-05-31StandaloneCash and deposits
Cash & equivalents¥765mat 2022-11-30StandaloneCash and cash equivalents
Cash & equivalents¥865mat 2022-05-31StandaloneCash and cash equivalents
Cash & equivalents¥839mat 2021-11-30StandaloneCash and cash equivalents
Cash & equivalents¥1.0bnat 2021-05-31dStandaloneCash and cash equivalents
Operating cash flow−¥58m2022-06-01 → 2022-11-30StandaloneNet cash provided by used in operating activities
Operating cash flow¥525m2021-06-01 → 2022-05-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥152m2021-06-01 → 2021-11-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥69m2022-06-01 → 2022-11-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥176m2021-06-01 → 2022-05-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥56m2021-06-01 → 2021-11-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥28m2022-06-01 → 2022-11-30StandaloneNet cash provided by used in financing activities
Financing cash flow−¥484m2021-06-01 → 2022-05-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥257m2021-06-01 → 2021-11-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥39.922022-06-01 → 2022-11-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥16.82022-09-01 → 2022-11-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥123.792021-06-01 → 2022-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥71.352021-06-01 → 2021-11-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥37.972021-09-01 → 2021-11-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥38.622022-06-01 → 2022-11-30StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥112.562021-06-01 → 2022-05-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥64.362021-06-01 → 2021-11-30StandaloneDiluted earnings per share (5-year summary)
Dividend per share¥192021-06-01 → 2022-05-31StandaloneDividend paid per share (5-year summary)
Equity ratio35.8%at 2022-11-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio35.0%at 2022-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio34.6%at 2021-11-30StandaloneEquity to asset ratio (5-year summary)
Shares issued4,095,500at 2022-11-30StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2022-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2021-11-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentrevenue2022-06-01 → 2022-11-30¥965m
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentrevenue external2022-06-01 → 2022-11-30¥965m
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentsegment profit2022-06-01 → 2022-11-30−¥20m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentrevenue2022-06-01 → 2022-11-30¥377m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentrevenue external2022-06-01 → 2022-11-30¥377m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentsegment profit2022-06-01 → 2022-11-30−¥39m
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentrevenue2022-06-01 → 2022-11-30¥1.8bn
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2022-06-01 → 2022-11-30¥1.8bn
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2022-06-01 → 2022-11-30¥284m
—segment totalrevenue2022-06-01 → 2022-11-30¥3.1bn
—segment totalrevenue external2022-06-01 → 2022-11-30¥3.1bn
—segment totalsegment profit2022-06-01 → 2022-11-30¥225m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2022-11-30¥3.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2022-11-30¥3.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2022-11-30¥225m
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentrevenue2021-06-01 → 2021-11-30¥956m
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentrevenue external2021-06-01 → 2021-11-30¥956m
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentsegment profit2021-06-01 → 2021-11-30¥5m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentrevenue2021-06-01 → 2021-11-30¥488m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentrevenue external2021-06-01 → 2021-11-30¥488m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentsegment profit2021-06-01 → 2021-11-30¥40m
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentrevenue2021-06-01 → 2021-11-30¥1.4bn
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2021-06-01 → 2021-11-30¥1.4bn
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2021-06-01 → 2021-11-30¥278m
—segment totalrevenue2021-06-01 → 2021-11-30¥2.8bn
—segment totalrevenue external2021-06-01 → 2021-11-30¥2.8bn
—segment totalsegment profit2021-06-01 → 2021-11-30¥323m
Total Of Reportable Segments And Otherssegment totalrevenue2021-06-01 → 2021-11-30¥2.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-06-01 → 2021-11-30¥2.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-06-01 → 2021-11-30¥323m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 495
ItemContextValueUnit
Gross profitCurrentYTDDuration_NonConsolidatedMember894360000JPY
Salaries and allowances sgaPrior1YTDDuration_NonConsolidatedMember226777000JPY
Salaries and allowances sgaCurrentYTDDuration_NonConsolidatedMember224587000JPY
Legal welfare expenses sgaPrior1YTDDuration_NonConsolidatedMember50602000JPY
Legal welfare expenses sgaCurrentYTDDuration_NonConsolidatedMember50976000JPY
Provision for bonuses sgaPrior1YTDDuration_NonConsolidatedMember49491000JPY
Provision for bonuses sgaCurrentYTDDuration_NonConsolidatedMember51275000JPY
Retirement benefit expenses sgaPrior1YTDDuration_NonConsolidatedMember6931000JPY
Retirement benefit expenses sgaCurrentYTDDuration_NonConsolidatedMember7307000JPY
Share based compensation expenses sgaPrior1YTDDuration_NonConsolidatedMember887000JPY
Share based compensation expenses sgaCurrentYTDDuration_NonConsolidatedMember4251000JPY
Provision for directors retirement benefits sgaPrior1YTDDuration_NonConsolidatedMember6200000JPY
Provision for directors retirement benefits sgaCurrentYTDDuration_NonConsolidatedMember-JPY
Other sgaPrior1YTDDuration_NonConsolidatedMember290927000JPY
Other sgaCurrentYTDDuration_NonConsolidatedMember330551000JPY
Selling general and administrative expensesPrior1YTDDuration_NonConsolidatedMember631818000JPY
Selling general and administrative expensesCurrentYTDDuration_NonConsolidatedMember668951000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember323255000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember225409000JPY
Interest income noiPrior1YTDDuration_NonConsolidatedMember0JPY
Interest income noiCurrentYTDDuration_NonConsolidatedMember18000JPY
Dividends income noiPrior1YTDDuration_NonConsolidatedMember792000JPY
Dividends income noiCurrentYTDDuration_NonConsolidatedMember781000JPY
Foreign exchange gains noiPrior1YTDDuration_NonConsolidatedMember5007000JPY
Foreign exchange gains noiCurrentYTDDuration_NonConsolidatedMember-JPY
Subsidy income noiPrior1YTDDuration_NonConsolidatedMember-JPY
Subsidy income noiCurrentYTDDuration_NonConsolidatedMember851000JPY
Insurance fee income noiPrior1YTDDuration_NonConsolidatedMember1761000JPY
Insurance fee income noiCurrentYTDDuration_NonConsolidatedMember3565000JPY
Other noiPrior1YTDDuration_NonConsolidatedMember2012000JPY
Other noiCurrentYTDDuration_NonConsolidatedMember1460000JPY
Non operating incomePrior1YTDDuration_NonConsolidatedMember9574000JPY
Non operating incomeCurrentYTDDuration_NonConsolidatedMember6676000JPY
Interest expenses noePrior1YTDDuration_NonConsolidatedMember8664000JPY
Interest expenses noeCurrentYTDDuration_NonConsolidatedMember8289000JPY
Foreign exchange losses noePrior1YTDDuration_NonConsolidatedMember-JPY
Foreign exchange losses noeCurrentYTDDuration_NonConsolidatedMember15308000JPY
Other noePrior1YTDDuration_NonConsolidatedMember502000JPY
Other noeCurrentYTDDuration_NonConsolidatedMember577000JPY
Non operating expensesPrior1YTDDuration_NonConsolidatedMember9166000JPY
Non operating expensesCurrentYTDDuration_NonConsolidatedMember24175000JPY
Ordinary incomePrior1YTDDuration_NonConsolidatedMember323663000JPY
Ordinary incomeCurrentYTDDuration_NonConsolidatedMember207911000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration_NonConsolidatedMember7000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration_NonConsolidatedMember0JPY
Extraordinary lossPrior1YTDDuration_NonConsolidatedMember7000JPY
Extraordinary lossCurrentYTDDuration_NonConsolidatedMember0JPY
Income before income taxesPrior1YTDDuration_NonConsolidatedMember323655000JPY
Income before income taxesCurrentYTDDuration_NonConsolidatedMember207911000JPY
Income taxes currentPrior1YTDDuration_NonConsolidatedMember18245000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2022-05-31pass rounding
balance sheet identitynon_consolidated 2022-11-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-05-31pass
statement vs summary · net assetsnon_consolidated 2022-11-30pass
statement vs summary · operating cash flownon_consolidated 2021-06-01/2021-11-30pass
statement vs summary · operating cash flownon_consolidated 2022-06-01/2022-11-30pass
statement vs summary · revenuenon_consolidated 2021-06-01/2021-11-30pass
statement vs summary · revenuenon_consolidated 2022-06-01/2022-11-30pass
statement vs summary · total assetsnon_consolidated 2022-05-31pass
statement vs summary · total assetsnon_consolidated 2022-11-30pass